Lobbying Relationship

Client

Otsuka Pharmaceutical Development & Commercialization, Inc.

More records

Lobbying firm

Otsuka Pharmaceutical Development & Commercialization, Inc.

More records

  • S.1945 - Mental Health Reform Act of 2015, S.481 - Improving Regulatory Transparency for New Medical Therapies Act, S.1893 - Mental Health Awareness and Improvement Act of 2015, H.R.2624 - Helping Families in Mental Health Crisis Act of 2015

Duration: to

General Issues: Health Issues, Government Issues, Alcohol & Drug Abuse, Consumer Issues/Safety/Protection, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Science/Technology

Spending: about $1,010,000 (But it's complicated. Here's why.)

Agencies lobbied since 2015: U.S. Senate, House of Representatives

Affiliated organizations: Otsuka America Pharmaceutical, Inc.

Related Foreign Entities: Otsuka Phamaceutical Co., Inc. (Chiyoda-ku, Tokyo, JPN); contribution to lobbying: $0; ownership 100%

Bills mentioned

S.1945: Mental Health Reform Act of 2015

Sponsor: Bill Cassidy (R-La.)

S.481: Improving Regulatory Transparency for New Medical Therapies Act

Sponsor: Orrin G. Hatch (R-Utah)

S.1893: Mental Health Awareness and Improvement Act of 2015

Sponsor: Lamar Alexander (R-Tenn.)

H.R.2624: Part D Beneficiary Appeals Fairness Act

Sponsor: Hank Johnson (D-Ga.)

H.R.2646: Helping Families in Mental Health Crisis Act of 2016

Sponsor: Tim Murphy (R-Pa.)

H.R.6: 21st Century Cures Act

Sponsor: Fred Upton (R-Mich.)

H.R.9: Innovation Act

Sponsor: Robert W. Goodlatte (R-Va.)

H.R.639: Improving Regulatory Transparency for New Medical Therapies Act

Sponsor: Joe Pitts (R-Pa.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Heide Bajnrauh Intrn, Sen McCain, 94-96; LSA, 96-97
Todd Tuten Rep Michael Bilirakis; 91-92, 93-95, 98-01
Molly Ryan n/a
Richard Thompson n/a
John Jonas n/a
Karen Thiel n/a
Eli Tomar n/a
John Bardi n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Amendment
Q3 Report
Q2 Report
Q1 Report
Registration
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page